Tag: Therapy & Procedures: Misc.
Glecaprevir and Pibrentasvir Aid HCV D+/R− Kidney Transplants
Two studies demonstrate safe transplant of kidneys from deceased donors with HCV infection
Lack of Knowledge Barrier to Prone Positioning Use in ARDS
Implementation strategies developed included educational outreach, learning collaborative
More Than Half of Cancer Patients Willing to Enroll in Clinical Trials
Participation rates similar for Black and White patients, treatment and cancer control trials
Remote Ischemic Postconditioning May Aid Stroke Recovery
More patients with acute ischemic stroke in RIPC group had excellent recovery at three months
Fecal Transplant Safe, Effective for C. Difficile Through Six Months
90 percent of those undergoing FMT had one-month cure; 4 percent had recurrence within six months
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
Benefit only seen for composite outcome, not for major or minor bleeding incidents
No Proof Convalescent Plasma Effective Against COVID-19
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
